InsiderTrades

Form 4 for TMDX TransMedics Group, Inc.

Accepted 2024-11-07 00:00:00 ET · period of report 2024-11-05 · accession 0000950170-24-123425 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DT 2024-11-07 2024-11-05 TMDX Basile Edward M Dir M - OptEx $28.12 +6,750 7,482 +922% +$189.8K
DMT 2024-11-07 2024-11-05 TMDX Basile Edward M Dir S - Sale+OE $83.55 -6,750 2,186 -76% -$564.0K
DT 2024-11-07 2024-11-05 TMDX Basile Edward M Dir M - OptEx $0.00 -6,750 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-11-05 M A 6,750 $28.12 7,482 D — —
2 Common Common Stock 2024-11-05 S D 1,454 $84.30 732 D — — (F3) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $84.00 to $84.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
3 Common Common Stock 2024-11-05 S D 5,296 $83.35 2,186 D — — (F2) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $82.91 to $83.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
4 Derivative Stock Option (Right to Buy) 2024-11-05 M D 6,750 $0.00 0 D $28.12 · — to 2032-06-01 6,750 Common Stock (F4) The option is fully vested.